Baskin School of Engineering
Adjunct Professor
Faculty
Jack Baskin Engineering Building
TBA
SOE2
Ahmed M. Hamdy, M.D. Dr. Hamdy has served as our Chief Executive Officer and Chairman of Vincerx Pharma board of directors since December 2020. Dr. Hamdy co-founded Vincera Pharma and served as its Chief Executive Officer and as a member of its board of directors from March 2019 to December 2020. Prior to that, Dr. Hamdy co-founded Acerta Pharma, a pharmaceutical development company and member of the AstraZeneca plc, and served as its head of early clinical development from January 2015 to June 2019, as chief executive officer from February 2013 to January 2015, as chief medical officer from February 2013 to January 2015 and as a member of the board from February 2013 to February 2016. Prior to that, Dr. Hamdy served as chief medical officer of Pharmacyclics LLC, a biopharmaceutical company, from March 2008 to June 2011. Dr. Hamdy has served as a clinical advisor and member of the board of directors of Andes Biotechnologies, a nucleic acid-based drug discovery and development company, since September 2016, as a member of the Dean’s Council of the Jack Baskin School of Engineering at the University of California, Santa Cruz, since April 2019, and as a member of the Palo Alto Medical Foundation President’s Council since March 2016. Dr. Hamdy received a MBBCH from the KasrAlainy School of Medicine at the University of Cairo, Egypt. Dr. Hamdy has more than twenty years of clinical research experience in pharmaceutical drug development and extensive executive leadership experience in the pharmaceutical drug development industry.
- Translational Biomedical Research
- Clinical Development
- Drug development
- Cancer research
- Kinase inhibitors
- Bruton's Tyrosine Kinase
- Oncogenic cancer drivers
PTEFB/CDK9
BTK
Oncogenic Drivers
Translational Biomedical Research
https://scholar.google.com/citations?user=-ab-JsMAAAAJ&hl=en